Response to Letter Regarding Article, “The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio”

The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio

Circulation ◽

10.1161/circulationaha.107.690396 ◽

2007 ◽

Vol 116 (3) ◽

pp. 268-275 ◽

Cited By ~ 56

Author(s):

Susan J. Hood ◽

Kevin P. Taylor ◽

Michael J. Ashby ◽

Morris J. Brown

Keyword(s):

Crossover Trial ◽

Double Blind ◽

Faculty Opinions recommendation of The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1089610.544876 ◽

2007 ◽

Author(s):

William Rainey

Keyword(s):

Crossover Trial ◽

Double Blind ◽

Letter Regarding Article by Hood et al, “The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio”

Circulation ◽

10.1161/circulationaha.107.738757 ◽

2008 ◽

Vol 117 (5) ◽

Author(s):

Paolo Mulatero ◽

Alberto Milan ◽

Franco Veglio

Keyword(s):

Crossover Trial ◽

Double Blind ◽

1367: A Randomised Double Blind Crossover Trial of Melatonin to Treat Nocturia in Men with Benign Prostatic Hypertrophy

The Journal of Urology ◽

10.1016/s0022-5347(18)38592-6 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 360-360

Author(s):

Marcus J. Drake ◽

Jeremy G. Noble ◽

Ian Mills

Keyword(s):

Crossover Trial ◽

Benign Prostatic Hypertrophy ◽

Prostatic Hypertrophy ◽

A Randomized, Double-Blind, Crossover Trial of Modafinil on Mood

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)70776-x ◽

2008 ◽

Vol 2008 ◽

pp. 198-199

Author(s):

J.C. Ballenger

Keyword(s):

Crossover Trial ◽

ACCURATE PAIN REPORTING TRAINING DIMINISHES THE PLACEBO RESPONSE: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, CROSSOVER TRIAL

10.26226/morressier.598b05d9d462b80290b539fe ◽

2017 ◽

Author(s):

Roi Treister

Keyword(s):

Crossover Trial ◽

Placebo Response ◽

Double Blind ◽

Pain Reporting

Faculty Opinions recommendation of A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1070820.523755 ◽

2007 ◽

Author(s):

Andrew Wilcock

Keyword(s):

Advanced Cancer ◽

Crossover Trial ◽

Double Blind ◽

Effect Of Oxygen

Faculty Opinions recommendation of Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1168153.630287 ◽

2009 ◽

Author(s):

Joel Katz ◽

Hance Clarke

Keyword(s):

Neuropathic Pain ◽

Crossover Trial ◽

Double Blind ◽

Randomised Controlled

Faculty Opinions recommendation of Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13445981.14821086 ◽

2012 ◽

Author(s):

Luca Persani

Keyword(s):

Crossover Trial ◽

Metabolic Effects ◽

Faculty Opinions recommendation of Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13911956.15365056 ◽

2012 ◽

Author(s):

Chim Lang

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Ursodeoxycholic Acid ◽

Crossover Trial ◽